Endo International (ENDP) Income Statement

Click line-items for a historical chart and %

Net pharmaceutical product sales	422.03M
Device, service and other revenues	-127.46M
TOTAL REVENUES	426.93M
Cost of revenues	156.45M
Selling, general and administrative	159.9M
Research and development	28.73M
Impairment of other intangible assets
Acquisition-related items	1.79M
OPERATING INCOME	-717.11M
INTEREST EXPENSE, NET	43.66M
LOSS ON EXTINGUISHMENT OF DEBT, NET	0
OTHER INCOME, NET	902K
Total consolidated income before income tax	-761.68M
INCOME TAX	-96.85M
CONSOLIDATED NET INCOME	-761.74M
Less: Net income attributable to noncontrolling interests	14.17M
NET INCOME ATTRIBUTABLE TO ENDO PHARMACEUTICALS HOLDINGS INC.	-775.91M
Basic net income per share	-6.85
Diluted net income per share	-6.82
Basic	-224.78M
Diluted	-237.38M

Entities mentioned with ENDP

View All Entities